Activist 13D/13G Filings - BAKER BROS. ADVISORS LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...9, 10, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-11-24
1:43 pm
Purchase
13DBellicum Pharmaceuticals, Inc.
BLCM
BAKER BROS. ADVISORS LP2,365,472
19.99%
167,553increase
(+7.62%)
View
2023-11-21
5:24 pm
Sale
13DMadrigal Pharmaceuticals, Inc.
MDGL
BAKER BROS. ADVISORS LP1,987,702
9.99%
-28,058decrease
(-1.39%)
View
2023-11-14
5:18 pm
Sale
13DBeiGene, Ltd.
BGNE
BAKER BROS. ADVISORS LP138,678,037
13%
-14,300,000decrease
(-9.35%)
View
2023-11-13
4:22 pm
Purchase
13GCerus Corporation
CERS
BAKER BROS. ADVISORS LP19,101,876
10.5%
3,014,454increase
(+18.74%)
View
2023-10-10
4:42 pm
Sale
13DNeoleukin Therapeutics, Inc.
NLTX
BAKER BROS. ADVISORS LP1,894,669
19.99%
-7,577,429decrease
(-80.00%)
View
2023-10-05
4:36 pm
Purchase
13DMadrigal Pharmaceuticals, Inc.
MDGL
BAKER BROS. ADVISORS LP2,015,760
9.99%
470,647increase
(+30.46%)
View
2023-08-17
5:12 pm
Sale
13DNeoleukin Therapeutics, Inc.
NLTX
BAKER BROS. ADVISORS LP9,472,098
19.99%
-570,979decrease
(-5.69%)
View
2023-08-10
4:42 pm
Sale
13GMereo BioPharma Group plc
MREO
BAKER BROS. ADVISORS LP14,604,391
2.2%
-54,754,968decrease
(-78.94%)
View
2023-08-10
4:39 pm
Sale
13GVerastem, Inc.
VSTM
BAKER BROS. ADVISORS LP0
0%
-1,345,192decrease
(Position Closed)
View
2023-08-08
5:16 pm
Unchanged
13DMadrigal Pharmaceuticals, Inc.
MDGL
BAKER BROS. ADVISORS LP1,545,113
8.4%
0
(Unchanged)
View
2023-07-19
5:28 pm
Purchase
13DNeoleukin Therapeutics, Inc.
NLTX
BAKER BROS. ADVISORS LP10,043,077
19.99%
5,813,250increase
(+137.43%)
View
2023-06-28
5:01 pm
Purchase
13DIGM Biosciences, Inc.
IGMS
BAKER BROS. ADVISORS LP3,277,567
9.99%
107,673increase
(+3.40%)
View
2023-06-16
7:18 pm
Unchanged
13DMadrigal Pharmaceuticals, Inc.
MDGL
BAKER BROS. ADVISORS LP1,545,113
8.4%
0
(Unchanged)
View
2023-06-12
4:37 pm
Sale
13GVerastem, Inc.
VSTM
BAKER BROS. ADVISORS LP1,345,192
8%
-25,643,706decrease
(-95.02%)
View
2023-06-02
4:06 pm
Purchase
13DTScan Therapeutics, Inc.
TCRX
BAKER BROS. ADVISORS LP2,793,938
6.5%
9,146increase
(+0.33%)
View
2023-05-24
5:11 pm
Purchase
13DACADIA Pharmaceuticals Inc.
ACAD
BAKER BROS. ADVISORS LP43,227,599
26.5%
920,810increase
(+2.18%)
View
2023-05-24
4:31 pm
Purchase
13DPrelude Therapeutics Incorporated
PRLD
BAKER BROS. ADVISORS LP10,219,080
19.5%
92,663increase
(+0.92%)
View
2023-05-05
4:33 pm
Sale
13DBeiGene, Ltd.
BGNE
BAKER BROS. ADVISORS LP152,978,037
13%
-1,337,453decrease
(-0.87%)
View
2023-05-05
4:24 pm
Sale
13DBellicum Pharmaceuticals, Inc.
BLCM
BAKER BROS. ADVISORS LP2,197,919
19.99%
-293,325decrease
(-11.77%)
View
2023-05-03
4:15 pm
Sale
13DSeagen Inc.
SGEN
BAKER BROS. ADVISORS LP45,074,469
24%
-2,159,182decrease
(-4.57%)
View
Goto 0, 1, 2, ...9, 10, Next